Study of the Mechanism ofTamoxifen-induced growth inhibition and its signal transduction pathway in estrogen-receptor negative non-small cell lung cancer cells
博士 === 高雄醫學大學 === 醫學研究所 === 90 === Tamoxifen, originally synthesized as an anti-estrogen drug, was found to be able to inhibit proliferation of estrogen receptor (ER)-negative cancer cells in vitro. However, the molecular basis of such ER-independent growth inhibition is unknown. In this...
Main Authors: | TeHsiu Lee, 李德修 |
---|---|
Other Authors: | WenChun Hung |
Format: | Others |
Language: | zh-TW |
Published: |
2002
|
Online Access: | http://ndltd.ncl.edu.tw/handle/19475828874576703877 |
Similar Items
-
In Vitro Study of Tamoxifen–induced growth inhibition in estrogen–receptor negative Glioma cells
by: Tsung–Che Lee, et al.
Published: (2011) -
Role of estrogen in lung cancer based on the estrogen receptor-epithelial mesenchymal transduction signaling pathways
by: Zhao XZ, et al.
Published: (2015-10-01) -
Response of negative estrogen-receptor hepatocarcinoma to tamoxifen, and survival of non-resectable patients
by: Jorge García-Leiva, et al.
Published: (2006-10-01) -
Profiling of gene expression regulated by 17β-estradiol and tamoxifen in estrogen receptor-positive and estrogen receptor-negative human breast cancer cell lines
by: Rangel N, et al.
Published: (2017-09-01) -
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
by: Pin Gao, et al.
Published: (2018-09-01)